AS WARRANT AGENT FORM OF ORDINARY SHARES WARRANT AGREEMENT DATED AS OF __________ AUTOLUS THERAPEUTICS PLC FORM OF ORDINARY SHARES WARRANT AGREEMENTWarrant Agreement • February 8th, 2024 • Autolus Therapeutics PLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 8th, 2024 Company Industry JurisdictionTHIS ORDINARY SHARES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between AUTOLUS THERAPEUTICS PLC, a public limited company incorporated under the laws of England and Wales under company number 11185179 and having its registered office at The Media Works, 191 Wood Lane, London W12 F7P, United Kingdom (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
PAGAYA TECHNOLOGIES LTD. AND _____________, AS WARRANT AGENT FORM OF CLASS A ORDINARY SHARES WARRANT AGREEMENT DATED AS OF __________Warrant Agreement • October 4th, 2023 • Pagaya Technologies Ltd. • Finance services • New York
Contract Type FiledOctober 4th, 2023 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated as of [l], between Pagaya Technologies Ltd., a company organized under the laws of the State of Israel (the “Company”), and [l], a [corporation] [national banking association] organized and existing under the laws of [l] and having a corporate trust office in [l], as warrant agent (the “Warrant Agent”).
RENALYTIX PLC AND _____________, AS WARRANT AGENT FORM OF ORDINARY SHARES WARRANT AGREEMENT DATED AS OF __________Warrant Agreement • September 28th, 2023 • Renalytix PLC • Services-medical laboratories • New York
Contract Type FiledSeptember 28th, 2023 Company Industry JurisdictionTHIS ORDINARY SHARES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between RENALYTIX PLC, a public limited company incorporated under the laws of England and Wales under company number 11257655 and having its registered office at Finsgate, 5-7 Cranwood Street, London EC1V 9EE, United Kingdom (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
NEUROBO PHARMACEUTICALS, INC. AND __________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF _____________Warrant Agreement • May 14th, 2021 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2021 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT(this “Agreement”), dated as of [•], between NEUROBO PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
AUTOWEB, INC. And ___________, as Warrant Agent Form Of Preferred Stock Warrant Agreement Dated As Of ___________ AUTOWEB, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENTWarrant Agreement • November 5th, 2020 • AutoWeb, Inc. • Services-computer programming, data processing, etc. • New York
Contract Type FiledNovember 5th, 2020 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this "Agreement"), dated as of [●], between AUTOWEB, INC., a Delaware corporation (the "Company") and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the "Warrant Agent").
AUTOWEB, INC. And ___________, as Warrant Agent Form Of Preferred Stock Warrant Agreement Dated As Of ___________ AUTOWEB, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENTWarrant Agreement • November 5th, 2020 • AutoWeb, Inc. • Services-computer programming, data processing, etc. • New York
Contract Type FiledNovember 5th, 2020 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this "Agreement"), dated as of [●], between AUTOWEB, INC., a Delaware corporation (the "Company") and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the "Warrant Agent").
Lineage Cell Therapeutics, Inc. and ________, as Warrant Agent Form of Preferred Share Warrant Agreement Dated as of ___________Warrant Agreement • May 1st, 2020 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 1st, 2020 Company Industry JurisdictionThis Preferred Share Warrant Agreement (this “Agreement”), dated as of between Lineage Cell Therapeutics, Inc., a California corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
MGT CAPITAL INVESTMENTS, INC. FORM OF WARRANT AGREEMENTWarrant Agreement • July 23rd, 2018 • MGT Capital Investments Inc • Patent owners & lessors • New York
Contract Type FiledJuly 23rd, 2018 Company Industry JurisdictionWARRANT AGREEMENT (this “Agreement”), dated as of [ ] between MGT CAPITAL INVESTMENTS, INC., a Delaware corporation (the “Company”) and [ ], a [corporation] [national banking association] organized and existing under the laws of [ ] and having a corporate trust office in [ ], as warrant agent (the “Warrant Agent”).
TELARIA, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 6th, 2017 • Telaria, Inc. • Services-advertising agencies • New York
Contract Type FiledNovember 6th, 2017 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between TELARIA, INC., a Delaware corporation (the “Company”) and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
NEXVET BIOPHARMA PUBLIC LIMITED COMPANY AND [●], AS WARRANT AGENT FORM OF PREFERENCE SHARES WARRANT AGREEMENT DATED AS OF [●], 20[●]Warrant Agreement • April 22nd, 2016 • Nexvet Biopharma PLC • Pharmaceutical preparations • New York
Contract Type FiledApril 22nd, 2016 Company Industry JurisdictionTHIS PREFERENCE SHARES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between NEXVET BIOPHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
NEXVET BIOPHARMA PUBLIC LIMITED COMPANY AND [●], AS WARRANT AGENT FORM OF ORDINARY SHARES WARRANT AGREEMENT DATED AS OF [●], 20[●]Warrant Agreement • April 22nd, 2016 • Nexvet Biopharma PLC • Pharmaceutical preparations • New York
Contract Type FiledApril 22nd, 2016 Company Industry JurisdictionTHIS ORDINARY SHARE WARRANT AGREEMENT (this “Agreement”), dated as of [●], between NEXVET BIOPHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Cleveland BioLabs, Inc. and _____________, As Warrant Agent Form Of Common Stock Warrant Agreement Dated As Of __________Warrant Agreement • December 11th, 2013 • Cleveland Biolabs Inc • Services-commercial physical & biological research • New York
Contract Type FiledDecember 11th, 2013 Company Industry JurisdictionThis Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Cleveland BioLabs, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).